,outcome,arm 1,arm 2
0,intervention,,
0,"Protocol-defined cardiotoxicity was, total study group","13 % of TLC D-99 patients, 2 cases of CHF, 29 % of doxorubicin patients, 9 cases of CHF","13 % of TLC D-99 patients, 2 cases of CHF, 29 % of doxorubicin patients, 9 cases of CHF"
